Decreased expression of SNHG16 promotes miR‐605‐3p expression, which down‐regulates TRAF6 and NF‐κB signalling and thereby inhibits a series of metastatic effects in HCC cells. The gene discussed is TRAF6; the disease is hepatocellular carcinoma.